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Abstract
Background: High-throughput gene expression data can predict gene function through the ‘‘guilt by association’’ principle:
coexpressed genes are likely to be functionally associated.
Methodology/Principal Findings: We analyzed publicly available expression data on normal human tissues. The analysis is
based on the integration of data obtained with two experimental platforms (microarrays and SAGE) and of various measures
of dissimilarity between expression profiles. The building blocks of the procedure are the Ranked Coexpression Groups
(RCG), small sets of tightly coexpressed genes which are analyzed in terms of functional annotation. Functionally
characterized RCGs are selected by means of the majority rule and used to predict new functional annotations. Functionally
characterized RCGs are enriched in groups of genes associated to similar phenotypes. We exploit this fact to find new
candidate disease genes for many OMIM phenotypes of unknown molecular origin.
Conclusions/Significance: We predict new functional annotations for many human genes, showing that the integration of
different data sets and coexpression measures significantly improves the scope of the results. Combining gene expression
data, functional annotation and known phenotype-gene associations we provide candidate genes for several genetic
diseases of unknown molecular basis.
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Introduction
Among the open problems of molecular biology the functional
annotation of the human genome and the identification of genes
involved in genetic diseases are especially important. Expression data
on a genomic scale have been available for several years thanks to
various experimental techniques, and arewidely believed to contain a
wealth of information relevant to the solution of such problems.
Functional annotation based on expression data is usually
founded on the ‘‘guilt by association’’ principle: since there is a
strong correlation between coexpression and functional related-
ness, a gene found to be coexpressed with several others involved
in a given biological process can be predicted to be involved in the
same process [1–3]. Recent systematic studies have demonstrated
the soundness of the approach [4,5].
Typically the analysis proceeds in three steps: (1) definition of a
quantitative measure of dissimilarity between expression profiles, (2)
identification of groups of coexpressed genes, e.g. using clustering
algorithms (3) functional analysis of these groups using a controlled
annotation vocabulary such as the Gene Ontology (GO) [6,7].
In this work we analyze human normal tissues expression data with
a procedure combining data obtained with different experimental
techniques, and interpreted with different definitions of coexpression,
into a unified framework. Thanks to a stringent definition of
functional characterization this approach allows the generation of a
large set of high-confidence predictions in terms of functional
annotation and the identification of new candidate disease genes.
The distinctive features of our approach are:
N Integration of different datasets and measures of coexpression.
The working hypothesis behind this strategy is that different
experimental techniques and different definitions of dissimi-
larity measures explore different aspects of coexpression, and
therefore can be combined to maximize the useful information
obtained.
N Use of a rank-based procedure to generate groups of
coexpressed genes (Ranked Coexpression Groups - RCG),
without clustering algorithms.
N Use of the majority rule to determine the functional
characterization of the RCGs. Such highly stringent criterion
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on the genes included in the functionally characterized RCGs.
The Ranked Coexpression Groups were generated from
publicly available expression data on human normal tissues
obtained with Affymetrix microarrays and SAGE; for the
microarray data we used Euclidean distance and Pearson linear
dissimilarity, while for SAGE we also used two measures of
coexpression based on the Poisson distribution and originally
introduced in [8] in a different context.
The RCGs determined to be functionally characterized by the
majority rule were then used for two purposes:
1. to generate high-confidence functional predictions for the
genes included in the functionally characterized RCGs
2. to identify promising new candidate disease genes for OMIM
[9] phenotypes of unknown molecular basis, but for which one
or more genetic loci have been identified. These predictions are
based on the co-occurrence in functionally characterized
RCGs of genes known to cause similar phenotypes
Results and Discussion
Ranked Coexpression Groups
In this work we considered gene expression data derived from
human normal tissues with Affymetrix microarrays and with
SAGE, but the techniques we employed are readily generalized to
any high-throughput gene expression platform. Given a set of
expression data and a quantitative measure of coexpression, for
each gene in the dataset we defined a Ranked Coexpression
Group as the gene itself together with the k genes most closely
coexpressed with it.
Therefore from a gene expression dataset and a quantitative
measure of coexpression we generated a number of RCGs equal to
the number of genes in the dataset, each containing k+1 genes.
Contrary to the clusters generated by most clustering algorithms,
the RCGs can overlap each other.
Generating putative functional annotations
We defined a RCG to be functionally characterized if the
majority of the genes it contains share a functional annotation (GO
term). If a RCG was found to be functionally characterized by a
GO term, we assigned the same term to all the genes in the RCG
which were not annotated to it: in this way we produced a set of
predicted functional annotations.
The parameter k controls the sensitivity and specificity of the
method: with increasing k one obtains less predictions with a
smaller percentage of false positives (PFP, defined in the Methods)
in the functional predictions. We chose the smallest value of k
corresponding to an overall PFP of less than 1%, which turned out
to be k=6.
Our definition of functional characterization differs from the
one most commonly used, in which a cluster of genes is considered
functionally characterized if a GO term is significantly overrep-
resented among its member genes. Using the purely statistical
definition, a GO term can turn out to be significantly
overrepresented even if a relatively small fraction of the genes
are annotated to it. In this case annotating the other genes to the
term would probably generate a large fraction of false positives.
Our majority rule ensures a higher level of confidence for the
predicted annotations.
By limiting ourselves to Gene Ontology terms whose total
prevalence in all the genes included in the expression dataset is
lower than a given threshold M, we can make the majority rules
imply statistical overrepresentation. For example the probesets of
the Affymetrix data set we use can be associated to 18099 unique
genes: since we only consider GO terms whose prevalence among
these genes is #M=300, the situation of least statistical
significance is that of a RCG with 4 out of 7 genes annotated to
a term with total prevalence of 300, which corresponds to a P-
value of 2.5 10
26 (one-sided exact Fisher test). The converse is not
true, since for example a GO term whose total prevalence is 2,
found twice in a RCG, would be statistically overrepresented with
P-value 1.35 10
27 but would not be selected by the majority rule.
Datasets and measures of coexpression
We used human normal tissue gene expression data obtained
with Affymetrix and SAGE platforms. The Affymetrix data were
produced by the authors of Ref.[10] and deposited in the GEO
repository [11,12] under accession GSE3526 [13]. 353 microarray
experiments were performed on ten post-mortem donors,
representing 65 tissues including 20 distinct sites of the central
nervous system. On these data we used Euclidean distance and
Pearson linear dissimilarity as measures of coexpression.
The SAGE data were obtained from the CGAP web site [14],
limiting the download to the 66 libraries labeled as ‘‘normal
tissue’’. On the SAGE data we used Pearson linear dissimilarity,
Euclidean distance, and two different Poisson-based coexpression
measures introduced in Ref.[8], originally to define a similarity
measure between promoters based on counts of transcription
factor binding sites.
Each dataset/coexpression measure gave its own set of RCGs
and the corresponding predicted annotations. Table 1 shows the
number of predicted annotations obtained with the various
combinations, together with an estimate of the PFP obtained as
explained in the Methods section.
It would be possible to conclude from these data that, for
example, Pearson dissimilarity is the best predictor of functional
relatedness both for Affymetrix and SAGE data. However it
should be noted that:
N The signal to noise ratio is rather small for each dataset/
measure combination separately, as shown by the PFP values
shown in Table 1; and
N The overlap between the predicted annotations obtained with
different combinations is rather limited (Table 2). For example
the predictions obtained from microarray data and Euclidean
distance are definitely not a subset of the more numerous ones
obtained with Pearson dissimilarity.
Table 1. Predicted annotations.
dataset measure annotations PFP(%)
AFFY P 1882 0.26
AFFY E 925 0.61
SAGE P 738 1.26
SAGE E 374 2.53
SAGE D 414 2.33
SAGE O 539 1.70
Number of non-redundant predicted annotations obtained with the various
dataset/measure combinations, and the corresponding PFP. The coexpression
measures are: E: Euclidean; P: Pearson; D: Poisson ‘‘distinct’’; O: Poisson
‘‘overrepresentation’’.
doi:10.1371/journal.pone.0002439.t001
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usefully explore different aspects of coexpression: therefore the
most effective strategy is to consider the union of all such
predictions.
In particular, the small overlap between the predictions
obtained with Affymetrix and SAGE data is in agreement with
the results of Ref. [15]. In that paper it is shown, more generally,
that the overlap between pairs of coexpressed genes from
Affymetrix and SAGE experiments is significant but small. Our
results show however that data from both platform can be used to
obtain good quality functional prediction if a very stringent
selection is performed, such as the one defined by the majority rule
applied to RCGs.
Ref. [15] also provides a study of the ‘‘GO correlation’’ (fraction
of pairs of coexpressed genes sharing their most specific GO
annotation) as a function of the cutoff in Pearson correlation
coefficient used to define coexpression. For example, they observe
a very strong enrichment in GO correlation when the cutoff is set
at values of 0.8 or higher. For comparison, the average Pearson
correlation in all our Affymetrix (SAGE) RCGs is 0.785 (0.711),
while for functionally characterized ones it is 0.868 (0.836).
The result of our analysis is thus the union of the predicted
annotations produced by each combination, a total of 4058 non-
redundant associations between a gene and a GO term involving
2440 human genes and 255 GO terms (non-redundant means that
when the same gene was annotated to a term and to a descendant
of the same term in the GO graph, only the latter annotation was
retained). The PFP for this set of predictions can be estimated as
the weighted average of the PFPs of the single combinations to be
0.987%. The functional predictions are reported in Supporting
Information Text S1.
High-confidence annotations
While the PFP gives a general statistical measure of the
reliability of our predictions, it is possible to extract a high-
confidence subset of predicted annotations by estimating the
precision associated to each individual GO term through a leave-
one-out procedure.
First we produced, for each GO term, a list of recalled
annotations, that is a list of genes that are known to be associated
to the GO term and would be associated to the same term by the
method if the known association were to be ignored. Then, as in
[4], we defined the precision as the ratio between the number of
recalled associations and the total number of recalled and
predicted associations between annotated genes and the GO term.
We generated a list of GO terms with precision $50% for each
dataset/measure combination. Putting together the corresponding
functional predictions and eliminating redundancies, we ended up
with 758 high-confidence annotations involving 510 genes and 50
GO terms (Supporting Information Text S2)
Comparison with a SVM-based approach
In Ref. [4] a method based on a Support Vector Machine
(SVM) was introduced to solve the same problem, i.e. to generate
genome-wide predicted functional annotations based on normal-
tissue expression data. The authors produced a list of 3730
putative annotations with a precision of 50% or better. After
removing redundancies and selecting, as in our case, only the GO
terms with total prevalence of 300 or less, we are left with 1750
putative annotations, to be compared to the 758 high-confidence
annotations we obtained.
Such a difference could in principle be due to higher
effectiveness of the SVM method compared to the majority rule,
or to differences in the primary data used in the analysis, or both.
Therefore we decided to use our algorithm on the data used in [4],
with the known GO annotations provided in the supplementary
material of the same work. We proceeded exactly as described
before, using Pearson dissimilarity and Euclidean distance, and we
obtained a total of 1990 high-confidence annotations (Supporting
Information Text S3). Therefore, at least on this expression
dataset, the performance of the majority rule method is similar to
the SVM. Interestingly, 292 of our 1990 predictions are in
common with the SVM predictions. Such moderate degree of
overlap suggests that the two methods can explore different aspects
of the same expression data, and can therefore be considered as
complementary.
However our method has two main advantages over the use of
SVMs or other complex machine learning algorithms: first, it is
simple to implement and does not require much computational
power; and second, the RCGs, and in particular the functionally
characterized ones, can be further mined to obtain insight on
other biological problems. For example, in the next section we
show how RCGs can be used to predict new candidate disease
genes.
Using RCGs to find candidate disease genes
Since the RCGs could successfully be used to predict functional
annotations we asked whether they could also be useful in finding
new candidate disease genes. First, we verified that genes whose
mutations are known to cause similar phenotypes tend to appear
together in RCGs more often than expected by chance. We used
the similarity score between OMIM phenotypes developed in [16],
and we defined as similar two phenotypes with a similarity score
$0.4, as suggested in [16].
For each dataset/measure combination we counted the fraction of
RCGs containing at least two genes associated to similar phenotypes,
and compared it to the same fraction obtained after randomization of
the gene names. The results are shown in Fig. 1. All dataset/measure
combinations showed a significant enrichment of disease-associated
RCGs compared to randomized RCGs. Moreover, this enrichment
wasmuch larger for functionally characterized RCGscomparedto all
RCGs (as expected, since functional annotation and involvment in
genetic diseases are correlated).
These results suggest that RCGs, and especially functionally
characterized ones, can be used to predict new candidate genes for
those phenotypes for which only a genomic locus, and not an
individual gene, is known. We considered a gene to be a candidate
for a phenotype if
(a) its genomic location fell within a locus known to be
associated to the phenotype; and
Table 2. Overlap.
AFFY P AFFY E SAGE P SAGE E SAGE D SAGE O
AFFY P 1882 168 38 20 11 21
AFFY E 925 16 13 6 15
SAGE P 738 58 46 65
SAGE E 374 45 69
SAGE D 414 201
SAGE O 539
Overlap between the predicted annotations found by the various dataset/
measure combinations. E: Euclidean, P: Pearson, D: Poisson-distinct, O: Poisson-
overrepresentation.
doi:10.1371/journal.pone.0002439.t002
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containing at least two genes known to cause similar
phenotypes.
We obtained a total of 53 candidate disease genes for 33 orphan
loci (Table 3 and Supporting Information Text S4). A survey of
the corresponding OMIM records and the literature revealed that
18 of our candidates could have been selected as very likely on the
basis of the available evidence, because they are known to be
involved in phenotypes very similar to those associated to the
orphan loci. Seven of these cases have been already excluded, on a
purely clinical basis, because a mutation was found in a different
gene or because of a negative mutation screening. Nevertheless,
since mutations are usually searched for only within the annotated
exons, we believe that the decision to definitively rule out the
involvement of such genes should be taken cautiously. In these
cases, our results can be considered as further, independent
evidence which may justify the search for mutations in the
regulatory regions of the genes or the re-evaluation of possible
synonymous changes which may have been discovered in patients,
since they could in principle cause aberrant splicings [17,18].
In all of the other cases, our results represent completely new
and extremely focused working hypotheses about the possible
genetic origin and molecular basis of the mapped phenotype, of
which we report some remarkable examples.
Rosselli-Gulienetti (RG) syndrome (OMIM ID 225000) is a very
rare form of ectodermal dysplasia, associated with craniofacial
abnormalities such as cleft palate and lip, whose molecular basis is
completely unknown. Owing to phenotypic similarity with
Desmosterolosis (602398) and Smith-Lemli-Opitz Syndrome
(270400), our analysis provided Lathosterol 5-desaturase (SC5DL)
as a candidate for this disorder. Although missense mutations in
SC5DL are known to result in lathosterolosis, the complete
inactivation of the gene in mice led to a malformative syndrome
characterized by craniofacial defects, including cleft palate and
micrognathia, and limb patterning abnormalities [19]. These
malformations were consistent with impaired hedgehog signaling
and appeared to be a consequence of decreased cholesterol rather
than increased lathosterol [19]. Taken together, these facts
strongly suggest that null SC5DL mutations could cause RG
syndrome in humans.
Idiopathic basal ganglia calcification (IBGC1 - OMIM ID
213600) is a disorder of unknown origin mapped to Chr. 14q, a
locus that comprises 1250 potential candidates. Our analysis
suggests that this disorder is caused by mitochondrial disfunction,
and strongly restricts the field of likely candidate genes.
The candidate that we provide for autosomal nonlamellar and
nonerythrodermic ichthyosis (OMIM ID 604781) is CYP4F22, a
cytochrome P450 family member of unknown function that we
functionally associated with epidermal development. This result is
particularly interesting in the light of recent results showing that
another member of the family is implicated in a different form of
ichthyosis [20].
Finally, one of the predicted disease/gene associations strongly
suggests that our method could be of help in the identification of
genes involved in highly prevalent clinical phenotypes. Indeed, a
Quantitative Trait Locus for abdominal obesity (OMIM ID
605552) has been mapped on 3q27. The candidate that we
provide for this locus is ABCF3, an ATP-binding cassette-
containing gene of unknown function. Interestingly, on the basis
of our predicted annotation, this gene could be involved in the
synthesis of C21-steroid hormones, thus providing a strong
rationale for its potential involvement and for searching variants
of its sequence in obesity.
Conclusions
We have investigated publicly available gene expression data to
predict the function of human genes based on the guilt-by-
association principle. A new method based on small groups of
tightly coexpressed genes and the majority rule to obtain
functional predictions was used on various combinations of
datasets and measures of coexpression.
Even if it would be possible to rank these combinations by their
effectiveness in producing putative annotations, we showed that
the most effective approach is to integrate their results, since each
Figure 1. Enrichment of RCGs in genes involved in similar phenotypes. For each dataset/coexpresison measure combination we show the
fraction of RCGs associated to an OMIM phenotype as described in the text. The fraction is shown for functionally characterized RCGs (grey), all RCGs
(purple), and randomized RCGs (orange). The coexpression measures are: E: Euclidean; P: Pearson; D: Poisson ‘‘distinct’’; O: Poisson
‘‘overrepresentation’’.
doi:10.1371/journal.pone.0002439.g001
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while the overlap between the results of the different combinations
is limited.
While the method is simple and its implementation does not
require large computational power, we showed that it performs
similarly to a published method based on support vector machines.
The Ranked Coexpression Groups on which the method is based
can be used to gain insight into biological problems other than
functional annotation: as an example we used them to identify new
candidate disease genes.
Our main results are
N a set of 4058 non–redundant functional predictions, including
a subset of 758 high-confidence predictions; and
N a set of 53 candidate disease genes associated to 33 OMIM loci
with unknown molecular basis.
These results emphasize the crucial role that high-throughput
gene expression data can play in solving the outstanding problems
of molecular biology.
Methods
Expression data: microarray
Human normal tissue gene expression data generated by the
authors of Ref.[10] were downloaded from the Gene Expression
Omnibus [11,12]. The data were log-transformed and replicate
experiments corresponding to the same tissue were averaged, to
compensate for the highly variable number of replicate experi-
ments available for the 65 tissues considered.
The association between probesets and genes was obtained from
Ensembl [21,22], version 45. Logarithmic expression data for
probesets corresponding to the same Ensembl gene id were
averaged, while probesets not associated to any Ensembl id were
Table 3. Predicted disease genes.
Gene Phenotype Status
PCOLCE Ehlers-Danlos syndrome, type VIII A
KCNQ2 Electroencephalogram, low-voltage B*[24]
CACNA1H Microphthalmia, isolated, with cataract 1 A
MYF6 Scapuloperoneal myopathy A
COL2A1 Spondylometaphyseal dysplasia, Kozlowski type B#[25]
PSMB5 Basal ganglia calcification, idiopathic, 1 A
NEDD8 Basal ganglia calcification, idiopathic, 1 A
C14orf2 Basal ganglia calcification, idiopathic, 1 A
ENSG00000196992 Basal
ganglia
calcification,
idiopathic, 1
A
RSHL3 Craniometaphyseal dysplasia, autosomal recessive A
SC5DL Rosselli-Gulienetti syndrome A
DKFZp762E1312Holoprosencephaly A
TULP1 Spinocerebellar ataxia, autosomal recessive 3 A
NRSN1 Spinocerebellar ataxia, autosomal recessive 3 A
OPN1MW Microphthalmia, isolated, with coloboma 1 B
OPN1MW2 Microphthalmia, isolated, with coloboma 1 B
CACNA1F Albinism, ocular, type II B#[26]
OPN1LW Colorblindness, blue-mono-cone-monochromatic
type
B
OPN1MW Colorblindness, blue-mono-cone-monochromatic
type
B
OPN1MW2 Colorblindness, blue-mono-cone-monochromatic
type
B
NRK Megalocornea A
MYL2 Spinal muscular atrophy, distal, congenital
nonprogressive
A
TDG Spinal muscular atrophy, distal, congenital
nonprogressive
A
CAMK1D Refsum disease with increased pipecolic acidemia A
AIPL1 Cone-rod dystrophy 5 C$[27]
LOC257039 Glaucoma 1, open angle A
BFSP2 Glaucoma 1, open angle A
SLC35A1 Retinitis pigmentosa 25 A
IMPG1 Cone-rod dystrophy 7 A
ELOVL4 Cone-rod dystrophy 7 B$[28]
CNGA1 Stargardt disease 4 C
SAA4 Hyperlipidemia, combined, 2 A
CYP4F22 Ichthyosis, nonlamellar and nonerythrodermic,
congenital, autosomal
A
ACTA1 Muscular dystrophy, congenital, 1b B
CABC1 Muscular dystrophy, congenital, 1b A
APOA5 High density lipoprotein deficiency, 3 B
APOA4 High density lipoprotein deficiency, 3 B
BFSP1 Cataract, posterior polar, 3 B
PCP4L1 Cone-rod dystrophy, 8 A
ABCF3 Abdominal obesity-metabolic syndrome A
FOXE1 Cataract, autosomal recessive, early-onset, pulverulentA
MYOT Myopathy, distal 2 B%[29]
LOC493869 Myopathy, distal 2 A
CMYA5 Myopathy, distal 2 A
Gene Phenotype Status
KRT1 Exfoliative ichthyosis, autosomal recessive B
KRT75 Exfoliative ichthyosis, autosomal recessive A
KRT2 Exfoliative ichthyosis, autosomal recessive B
KRT5 Exfoliative ichthyosis, autosomal recessive B
KRT77 Exfoliative ichthyosis, autosomal recessive A
KRT6A Exfoliative ichthyosis, autosomal recessive A
FLNC Muscular dystrophy, limb-girdle, type 1f A
CRYBB1 Myopia 6 A
CRYBA4 Myopia 6 A
The gene name is the official HUGO name where available, or the Ensembl ID.
The third column summarizes the available information about the association of
candidates with the disease. In particular, genes annotated with A have to our
knowledge not been associated to the disease or to similar phenotypes, genes
annotated with B are involved in MIM phenotypes with phenomap scores of 0.4
or higher, genes annotated with C have been associated to similar phenotypes,
but display a phenomap score lower than 0.4. Moreover, genes annotated with
# represent the actual disease gene, because mutations have been found in
patients (but the association with the disease is not reported by Ensembl,
version 45); genes annotated with
* have been excluded on clinical basis; genes
annotated with $ can be excluded because mutations have been found in a
different gene; genes annotated % are at the moment excluded because they
have been screened but mutations have not been found. In all cases labeled by
special characters we also provide a reference to the corresponding supporting
evidence. More details are available in Supporting Information Text S4.
doi:10.1371/journal.pone.0002439.t003
Table 3. Cont.
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rows (Ensembl gene ids) and 65 columns (tissues), which was used
to construct the RCGs.
Expression data: SAGE
We used the SAGE library finder [23] to select all short-tag
libraries with normal tissue histology, obtaining 66 libraries, and
we downloaded the corresponding tag frequencies. An integer-
valued expression matrix was obtained by summing the tag counts
for all tags corresponding to the same Ensembl id. The translation
from tag to Ensembl id was performed using the tag-Unigene id
correspondence provided in the SAGE ftp site. We thus obtained
an expression matrix with 14031 rows and 66 columns, which was
used to construct the RCGs.
GO annotation
GO annotations for Ensembl gene ids were obtained from
Ensembl, version 45. Annotations with the ‘‘IEP’’ evidence code
were discarded as they refer to annotations inferred from
expression profiles, that is based on approaches similar to the
one used in this work.
Measures of coexpression
Given two genes in one of our expression matrices we used
different quantitative measures of coexpression to construct
independent sets of RCGs. Let X and Y be two genes, and their
expression values for the N columns of the matrix (tissues). The
expression data are real numbers for microarray data and integer
counts for SAGE.
The Pearson linear dissimilarity is defined as
dP X,Y ðÞ ~
1{rX ,Y ðÞ
2
where r is the Pearson correlation coefficient. This measure of
coexpression was used for both microarray and SAGE data.
The Euclidean distance is
dE X,Y ðÞ ~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
X N
i~1
xi{yi ðÞ
2
v u u t
Also this measure was applied to both microarray and SAGE data.
However the SAGE data were first normalized by dividing each
tag count by the total number of tags counted in the library.
We also used, on SAGE data, two measures of coexpression
based on the null hypothesis of Poissonian distribution of the tag
counts. These were proposed in Ref.[8] in a different context,
namely as a measure of similarity between promoter regions based
on transcription factor binding site counts. In particular we used
the two ‘‘dissimilarity metrics’’ introduced in Ref. [8].
They are both based on the null model in which the gene
expression levels for the i-th SAGE library follow a Poisson
distribution with expectation value given by the average gene
expression in the library.
The ‘‘dissimilarity-distinct’’ measure is defined by
dD X,Y ðÞ ~
1
N
X N
i~1
Fx i,mi ðÞ {Fy i,mi ðÞ jj
where F(x,m) is the Poisson distribution function, i.e. the probability
of observing #x occurrences if the expected number of
occurrences is m:
Fx ,m ðÞ ~e{m X x
k~0
mk
k!
Therefore dD(X,Y) gets from each library a contribution equal to
the area under the Poisson curve between xi and yi.
The ‘‘dissimilarity-overrepresentation’’ measure is based on the
idea of overrepresentation of a gene in a library. If the expression
level of gene X in the i-th library is xi, its overrepresentation is
measured by the Poissonian probability of having at least xi
occurrences:
1{Fx i{1,mi ðÞ
dO(X, Y) gets from each library a contribution equal to the
difference in overrepresentation between X and Y in the library:
dO X,Y ðÞ ~
1
N
X N
i~1
Fx i{1,mi ðÞ {Fy i{1,mi ðÞ jj
While the equations defining dD and dO look rather similar, it turns
out a posteriori that the RCGs and putative annotations they
produce are significantly different (see Table 2).
Other Poisson-based similarity measures are defined in [8],
which however are not suitable for the generation of RCGs since,
in practice, large number of genes turn out to have the same
coexpression with any given gene, so as to make the definition of
small RCGs problematic.
Estimating the percentage of false positives and
choosing k
For each combination of expression data and coexpression
measure we estimated the percentage of false positives (PFP)
among the putative gene annotations using randomized RCGs: we
randomized the gene names 100 times independently and
recorded the number of putative annotations obtained from each
set of randomized RCGs. The PFP for a given data/measure
combination is the ratio between the average number of predicted
annotations obtained from the randomized RCGs and the number
obtained from the true RCGs. The overall PFP is computed as the
average over the PFPs of the various combinations, each weighted
by the corresponding number of predicted annotations. When
increasing the value of k one systematically obtains less predictions
and a lower PFP. We decided to use the smallest k giving an
overall PFP less than 1%, which turned out to be k=6. For
comparison, the PFP for k=4 was 8.0%.
Identification of candidate disease genes
To verify the enrichment of RCGs in pairs of genes involved in
similar phenotypes we downloaded from Ensembl a list of
associations between human genes and phenotypes known to be
caused by their mutations. We defined two OMIM phenotypes to
be similar if their MimMiner [16] similarity score was $0.4. We
then computed the number of functionally characterized RCGs
including at least two genes associated to similar phenotypes and
compared it to the same number (a) for all RCGs and (b) averaged
over 100 randomized RCGs to produce Figure 1.
A list of 850 OMIM phenotypes with unknown molecular basis,
but for which one or more genomic loci have been identified, was
obtained from the OMIM site [9] on July 2nd, 2007. For the 602
such phenotypes for which MimMiner scores were available we
Gene Function from Expression
PLoS ONE | www.plosone.org 6 June 2008 | Volume 3 | Issue 6 | e2439identified the functionally characterized RCGs containing at least
two genes experimentally associated to similar phenotypes. Genes
in such RCGs, which were also located inside one of the genomic
loci associated to the phenotype of unknown molecular basis were
considered as candidate genes for the phenotype.
Supporting Information
Text S1 Non-redundant functional predictions for human genes.
Found at: doi:10.1371/journal.pone.0002439.s001 (0.80 MB
TXT)
Text S2 High-confidence non-redundant functional predictions
for human genes.
Found at: doi:10.1371/journal.pone.0002439.s002 (0.14 MB
TXT)
Text S3 High-confidence non-redundant functional predictions
for mouse genes based on the data of Ref.[4]
Found at: doi:10.1371/journal.pone.0002439.s003 (0.20 MB
TXT)
Text S4 Candidate genes for OMIM phenotypes of unknown
molecular basis. The first column reports the dataset/measure
combination(s) that allowed the selection of the candidate: 1 -
Pearson correlation coefficient on Affymetrix dataset; 2 -
Euclidean distance on Affymetrix dataset; 3 - Pearson correlation
coefficient on SAGE dataset; 4 - normalized Euclidean distance on
SAGE; 5 - Poisson-based ‘‘distinct’’ dissimilarity on SAGE; 6 -
Poisson-based ‘‘overrepresentation’’ dissimilarity on SAGE. Codes
for the available knowledge as in Tab. 3. The last column reports
the GO annotations associated to the functionally characterized
RCG(s) used to make the prediction
Found at: doi:10.1371/journal.pone.0002439.s004 (0.09 MB
XLS)
Acknowledgments
The authors of Ref. [16] kindly provided us with the complete MimMiner
scores.
Author Contributions
Conceived and designed the experiments: FD PP. Performed the
experiments: UA RP PP LM FR. Analyzed the data: LS FD UA RP PP
LM FR. Wrote the paper: PP.
References
1. Brown PO, Botstein D (1999) Exploring the new world of the genome with DNA
microarrays. Nat Genet 21: 33–37.
2. Quackenbush J (2001) Computational analysis of microarraydata. Nat Rev
Genet 2: 418–427.
3. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and
display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:
14863–14868.
4. Zhang W, Morris QD, Chang R, Shai O, Bakowski MA, et al. (2004) The
functional landscape of mouse gene expression. J Biol 3: 21.
5. Wolfe CJ, Kohane IS, Butte AJ (2005) Systematic survey reveals general
applicability of guilt-by-association within gene coexpression networks. BMC
Bioinformatics 6: 227.
6. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene
ontology: tool for the unification of biology. The Gene Ontology Consortium.
Nat Genet 25: 25–29.
7. The Gene Ontology. Available: http://www.geneontology.org/. Accessed 27
June 2007.
8. van Helden J (2004) Metrics for comparing regulatory sequences on the basis of
pattern counts. Bioinformatics 20: 399–406.
9. Online Mendelian Inheritance in Man. Available: http://www.ncbi.nlm.nih.
gov/omim/. Accessed July 2nd 2007.
10. Roth RB, Hevezi P, Lee J, Willhite D, Lechner SM, et al. (2006) Gene
expression analyses reveal molecular relationships among 20 regions of the
human CNS. Neurogenetics 7: 67–80.
11. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, et al. (2007) NCBI
GEO: mining tens of millions of expression profiles–database and tools update.
Nucleic Acids Res 35: D760–5.
12. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI
gene expression and hybridization array data repository. Nucleic Acids Res 30:
207–10].
13. Comparison of gene expression profiles across the normal human body.
Available: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? acc=GSE3526.
Accessed May 30th 2007.
14. The Cancer Genome Anatomy Project. Available: http://cgap.nci.nih.gov/.
Accessed July 1st 2007.
15. Griffith OL, Pleasance ED, Fulton DL, Oveisi M, Ester M, et al. (2005)
Assessment and integration of publicly available SAGE, cDNA microarray and
oligonucleotide microarray expression data for global coexpression analyses.
Genomics 86: 476–488.
16. van Driel MA, Bruggeman J, Vriend G, Brunner HG, Leunissen JAM (2006) A
text-mining analysis of the human phenome. Eur J Hum Genet 14: 535–542.
17. Faustino NA, Cooper TA (2003) Pre-mRNA splicing and human disease. Genes
Dev 17: 419–437.
18. Pagani F, Raponi M, Baralle FE (2005) Synonymous mutations in CFTR exon
12 affect splicing and are not neutral in evolution. Proc Natl Acad Sci U S A
102: 6368–6372.
19. Krakowiak PA, Wassif CA, Kratz L, Cozma D, Kovarova M, et al. (2003)
Lathosterolosis: an inborn error of human and murine cholesterol synthesis due
to lathosterol 5-desaturase deficiency. Hum Mol Genet 12: 1631–1641.
20. Lefevre C, Bouadjar B, Ferrand V, Tadini G, Megarbane A, et al. (2006)
Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. Hum
Mol Genet 15: 767–776.
21. Hubbard TJP, Aken BL, Beal K, Ballester B, Caccamo M, et al. (2007) Ensembl
2007. Nucleic Acids Res 35: 610–617.
22. Ensembl. Available: http://www.ensembl.org/. Accessed May 30th 2007.
23. Sage Library Finder. Available: http://cgap.nci.nih.gov/SAGE/SAGELibrary-
Finder. Accessed July 1st 2007.
24. Steinlein O, Anokhin A, Yping M, Schalt E, Vogel F (1992) Localization of a
gene for the human low-voltage EEG on 20q and genetic heterogeneity.
Genomics 12: 69–73.
25. Sulko J, Czarny-Ratajczak M, Wozniak A, Latos-Bielenska A, Kozlowski K
(2005) Novel amino acid substitution in the Y-position of collagen type II causes
spondyloepimetaphyseal dysplasia congenita. Am J Med Genet A 137: 292–297.
26. Wutz K, Sauer C, Zrenner E, Lorenz B, Alitalo T, et al. (2002) Thirty distinct
CACNA1F mutations in 33 families with incomplete type of XLCSNB and
Cacna1f expression profiling in mouse retina. Eur J Hum Genet 10: 449–456.
27. Udar N, Yelchits S, Chalukya M, Yellore V, Nusinowitz S, et al. (2003)
Identification of GUCY2D gene mutations in CORD5 families and evidence of
incomplete penetrance. Hum Mutat 21: 170–171.
28. Michaelides M, Holder GE, Hunt DM, Fitzke FW, Bird AC, et al. (2005) A
detailed study of the phenotype of an autosomal dominant cone-rod dystrophy
(CORD7) associated with mutation in the gene for RIM1. Br J Ophthalmol 89:
198–206.
29. Garvey SM, Senderek J, Beckmann JS, Seboun E, Jackson CE, et al. (2006)
Myotilin is not the causative gene for vocal cord and pharyngeal weakness with
distal myopathy (VCPDM). Ann Hum Genet 70: 414–416.
Gene Function from Expression
PLoS ONE | www.plosone.org 7 June 2008 | Volume 3 | Issue 6 | e2439